Prof. Christopher Coe, University of Wisconsin-Madison, United States

Prof. Christopher Coe is a distinguished professor emeritus in psychology at the University of Wisconsin-Madison, recognized for his pioneering work in psychoneuroimmunology and developmental psychobiology. With a career spanning leading institutions, he has made significant contributions to understanding the interaction of stress, immune function, and social behavior, earning numerous accolades for his research and teaching.

Author Profile:

Scopus Profile

Orcid Profile

Educational Details:

Prof. Christopher Coe, Professor Emeritus at the University of Wisconsin-Madison, is a distinguished expert in biological psychology and psychoneuroimmunology. He earned a B.A. in Anthropology (cum laude) with a minor in Biology from City College, City University of New York, in 1971, and a Ph.D. in Biological Psychology from Downstate Medical Center, SUNY, in 1976. Following this, he completed a postdoctoral fellowship in developmental psychobiology at Stanford University Medical School (1976-77). Prof. Coe’s career has been marked by groundbreaking research on the interplay between behavior, stress, and immune function, as well as exceptional contributions to teaching and academic leadership.

Professional Experience:

Prof. Christopher Coe has had an illustrious academic career spanning over five decades, beginning as a Lecturer at the American Museum of Natural History in New York (1970-71). He held key roles at Stanford University, including Postdoctoral Fellow (1976-77), Assistant Director of the Outdoor Primate Facility (1977-79), and Assistant Professor at the School of Medicine (1981-85). Joining the University of Wisconsin-Madison in 1985, he served as Associate Professor, Director of the Harlow Center for Biological Psychology, and later as Professor (1988-2022). Honored as the W.B. Cannon Professor of Biopsychology (2001-2022), he is now Professor Emeritus and Honorary Scholar.

Research Interests:

Prof. Christopher Coe’s research spans developmental psychobiology, psychoneuroimmunology, and sociophysiology. He investigates how early life experiences shape biological and psychological development, the interplay between stress, behavior, and immune system function, and the biological basis of social interactions and their effects on health and well-being.

Research Skills:

Prof. Christopher Coe specializes in designing and conducting longitudinal studies in developmental psychobiology, with expertise in psychoneuroimmunology and animal behavioral research. He is also proficient in sociophysiological measurement techniques and advanced data analysis, enabling a comprehensive understanding of the biological and behavioral dynamics underlying health and development.

Research Projects:

Prof. Christopher Coe has spearheaded pioneering research projects on the impact of stress and early life experiences on immune development, behavioral and physiological adaptations in primates, and the psychosocial factors influencing health and resilience throughout the lifespan.

Awards and Honors:

Prof. Christopher Coe has received numerous prestigious awards, including the Chancellor’s Award for Excellence in Teaching (1997), the WARF Professorship as W.B. Cannon Professor (2001), and the Norman Cousins Award for Psychoneuroimmunology Research (2001). Other honors include the Ziskind-Somerfield Award for Innovative Research (2004), the Hilldale Award for Teaching and Scholarship (2006), the P. Barchas Award for Sociophysiology Research (2008), and an Honorary Professorship from South China Normal University (2009). He also earned the Best Research in Health and Society accolade (2011) and the UW Board of Regents Teaching Excellence Award (2013).

Conclusion:

Prof. Christopher Coe’s career exemplifies excellence in academic leadership, innovative research, and impactful teaching. His contributions to psychology and biopsychology continue to inspire scholars and shape the understanding of health, behavior, and development.

Top Notable Publications:

Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease

Authors: Hansen, J.L., Rumble, M.E., Coe, C.L., Hematti, P., Costanzo, E.S.

Year: 2025

Citations: 0

Non-invasive ventral cervical magnetoneurography as a proxy of in vivo lipopolysaccharide-induced inflammation

Authors: Bu, Y., Burks, J., Yang, K., Coleman, T.P., Lerman, I.

Year: 2024

Citations: 0

Higher inflammatory proteins predict future depressive symptom severity among adolescents with lower emotional clarity

Authors: Stephenson, A.R., Ka-Yi Chat, I., Bisgay, A.T., Abramson, L.Y., Alloy, L.B.

Year: 2024

Citations: 0

Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts

Authors: Turner, D.G.P., De Lange, W.J., Zhu, Y., Ralphe, J.C., Glukhov, A.V.

Year: 2024

Citations: 2

Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys

Authors: Coe, C.L., Nimityongskul, F., Lubach, G.R., Rancour, D., Schomburg, F.M.

Year: 2024

Citations: 0

Exercise does not cause post-exertional malaise in Veterans with Gulf War Illness: A randomized, controlled, dose–response, crossover study

Authors: Boruch, A.E., Barhorst, E.E., Rayne, T.J., Cook, D.B., Lindheimer, J.B.

Year: 2024

Citations: 1

Financial Hardship and Age-Related Decrements in Kidney Function among Black and White Adults in the Midlife in the United States Study

Authors: Surachman, A., Harhay, M., Santos, A.R., Almeida, D.M., Coe, C.L.

Year: 2024

Citations: 1

Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents

Authors: Wood, E.K., Reid, B.M., Sheerar, D.S., Gunnar, M.R., Coe, C.L.

Year: 2024

Citations: 1

Prognostic Performance of Hematological and Serum Iron and Metabolite Indices for Detection of Early Iron Deficiency Induced Metabolic Brain Dysfunction in Infant Rhesus Monkeys

Authors: Sandri, B.J., Kim, J., Lubach, G.R., Coe, C.L., Rao, R.B.

Year: 2024

Citations: 3

The Impact of Early and Recent Life Stress on Trajectories of Inflammatory Biomarkers in a Diverse Sample of Adolescents

Authors: Kautz, M.M., McArthur, B.A., Moriarity, D.P., Abramson, L.Y., Alloy, L.B.

Year: 2023

Citations: 4

Songwen Chen | Arrhythmia | Best Research Article Award

Published on 13/12/202424/02/2025 by Cardiology and Cardiovascular Medicine

Dr. Songwen Chen | Arrhythmia | Best Research Article Award

Dr. Songwen Chen, Shanghai General Hospital, China

Dr. Songwen Chen is an Associate Chief Physician at Shanghai General Hospital and a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. He specializes in cardiology and electrophysiology, with extensive experience in catheter ablation for arrhythmias such as atrial fibrillation and ventricular tachycardia. Dr. Chen holds a doctorate in Internal Medicine from Shanghai Jiao Tong University and has published widely on topics including arrhythmia management, skin sympathetic nerve activity, and catheter-based interventions. He has received numerous research grants and plays a key role in educating future cardiologists. His work continues to advance both clinical practice and research in cardiology.

Profile:

Google scholar Profile

🎓 EDUCATION

Dr. Songwen Chen’s educational background is distinguished by his dedication to the field of medicine and cardiology. He earned his Bachelor’s degree in Medicine from Soochow University, followed by a Master’s degree in Internal Medicine from Fudan University’s Zhongshan Hospital. His pursuit of advanced knowledge continued with a Doctorate in Internal Medicine from Shanghai General Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This strong academic foundation in medical science has provided Dr. Chen with the expertise needed to excel in clinical cardiology and electrophysiology, enabling him to make significant contributions to both research and patient care.

💼 PROFESSIONAL EXPERIENCE:

Dr. Songwen Chen is an Associate Chief Physician in the Department of Cardiology at Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, where he has worked since 2012. In addition to his clinical duties, which include performing electrophysiology studies and catheter ablation for arrhythmias, he also supervises graduate students as a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. Dr. Chen has contributed extensively to research, securing several prestigious grants, and publishing numerous studies on topics such as arrhythmia management, electrophysiology, and catheter-based interventions. His professional experience blends clinical practice with significant academic and research achievements.

Research experience

Dr. Songwen Chen has extensive research experience in the field of cardiology, with a focus on electrophysiology and arrhythmia management. His work includes studying catheter ablation techniques for atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. Dr. Chen has made significant contributions to understanding the role of the inferior vena cava in triggering atrial fibrillation and exploring the relationship between skin sympathetic nerve activity and QT interval variability. He has published in prominent journals such as JACC: Clinical Electrophysiology and Pacing and Clinical Electrophysiology. His research is supported by prestigious grants and has led to innovative advancements in clinical cardiology.

Award And Honors

Dr. Songwen Chen has received several prestigious awards and honors throughout his career, reflecting his exceptional contributions to the field of cardiology. His groundbreaking research has been recognized with grants from prominent organizations such as the National Natural Science Foundation of China and the Shanghai Municipal Commission of Health and Family Planning. Additionally, his innovative work in electrophysiology and catheter ablation for arrhythmias has earned him widespread recognition within the medical community. Dr. Chen’s academic excellence, clinical expertise, and dedication to advancing cardiology make him a highly respected figure, deserving of continued recognition and accolades in his field.

Citations:

Citations – 914
h-index1 – 71
i10-index – 27

Conclusion:

Dr. Songwen Chen stands as a distinguished figure in cardiology, merging clinical expertise with impactful research and education. His dedication to advancing electrophysiology, combined with his leadership at Shanghai General Hospital and Shanghai Jiao Tong University School of Medicine, underscores his commitment to improving cardiovascular health outcomes. Dr. Chen’s work not only elevates patient care but also inspires the next generation of medical professionals, solidifying his legacy in the field of cardiology.

TOP NOTABLE PUBLICATIONS:

Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b
Authors: L Cai, B Qi, X Wu, S Peng, G Zhou, Y Wei, J Xu, S Chen, S Liu
Journal: Journal of Molecular and Cellular Cardiology
Year: 2019

Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis
Authors: X Li, JSK Chan, B Guan, S Peng, X Wu, X Lu, J Zhou, JMH Hui, YHA Lee, …
Journal: Cardiovascular diabetology
Year: 2022

Activated CD4+ T cells-derived exosomal miR-142-3p boosts post-ischemic ventricular remodeling by activating myofibroblast
Authors: L Cai, G Chao, W Li, J Zhu, F Li, B Qi, Y Wei, S Chen, G Zhou, X Lu, J Xu, …
Journal: Aging (Albany NY)
Year: 2020

Micro RNA‐30c suppresses the pro‐fibrogenic effects of cardiac fibroblasts induced by TGF‐β1 and prevents atrial fibrosis by targeting TGF β RII
Authors: J Xu, H Wu, S Chen, B Qi, G Zhou, L Cai, L Zhao, Y Wei, S Liu
Journal: Journal of Cellular and Molecular Medicine
Year: 2018

Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility
Authors: B Qi, Y Wei, S Chen, G Zhou, H Li, J Xu, Y Ding, X Lu, L Zhao, F Zhang, …
Journal: Cardiovascular research
Year: 2014

LCZ696 ameliorates oxidative stress and pressure overload‐induced pathological cardiac remodeling by regulating the Sirt3/MnSOD pathway
Authors: S Peng, X Lu, Y Qi, J Li, J Xu, T Yuan, X Wu, Y Ding, W Li, G Zhou, Y Wei, …
Journal: Oxidative Medicine and Cellular Longevity
Year: 2020

Blocking the pulmonary vein to left atrium conduction in addition to the entrance block enhances clinical efficacy in atrial fibrillation ablation
Authors: S Chen, W Meng, D Sheng He, G Chen, F Zhang, Y Yan, Y Zhu-Ge, …
Journal: Pacing and Clinical Electrophysiology
Year: 2012

Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: an in vivo approach
Authors: W Li, S Chen, G Zhou, H Li, L Zhong, S Liu
Journal: Saudi Journal of Biological Sciences
Year: 2018

Procedural arrhythmia termination and long‐term single‐procedure clinical outcome in patients with non‐paroxysmal atrial fibrillation
Authors: G Zhou, S Chen, G Chen, F Zhang, W Meng, Y Yan, X Lu, Y Wei, S Liu
Journal: Journal of Cardiovascular Electrophysiology
Year: 2013

Age-and sex-related difference in lipid profiles of patients hospitalized with acute myocardial infarction in East China
Authors: Y Wei, B Qi, J Xu, G Zhou, S Chen, P Ouyang, S Liu
Journal: Journal of Clinical Lipidology
Year: 2014

Xingang Li | harmacology | Best Research Article Award

Published on 12/12/202413/12/2024 by Cardiology and Cardiovascular Medicine

Prof. Xingang Li | pharmacology | Best Research Article Award

Prof. Xingang Li, Department of Pharmacy, Beijing Friendship Hospital, China

Prof. Xingang Li is the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, China, where he also serves as a Chief Pharmacist, Professor, and Ph.D. Supervisor. An expert in quantitative pharmacology and genetic pharmacology, Prof. Li has published over 50 articles in top-tier journals, with more than 1000 citations and an H-index of 20. He is an External Expert at the National Center for Drug Evaluation, a member of multiple prestigious pharmacological committees, and a reviewer for leading journals such as Biomaterials and Clin Transl Med. His research focuses on personalized medicine, drug delivery systems, and epigenetic influences on pharmacodynamics.

Profile:

Orcid Profile

🏥 Current Positions:

Prof. Li Xingang serves as the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, where he is also the Chief Pharmacist. As a Professor and Ph.D. Supervisor, he is instrumental in nurturing future generations of pharmacists and researchers. His leadership role involves overseeing advanced pharmacological practices, mentoring young scientists, and ensuring cutting-edge drug evaluation and management systems. With a strong emphasis on precision medicine, Prof. Li combines clinical expertise and research excellence to address pressing healthcare challenges.

📚 Academic Background:

Prof. Li has an extensive academic background, which underpins his outstanding contributions to quantitative pharmacology and genetic pharmacology. His role as an External Expert at the National Center for Drug Evaluation and Review Expert for the Beijing Science and Technology Plan Project showcases his authority in the field. His memberships in prestigious committees, such as the Quantitative Pharmacology Committee of the Chinese Pharmacological Society and the Epigenetics Committee, reflect his deep commitment to advancing pharmaceutical sciences.

🧪 Research Interests and Achievements:

Quantitative Pharmacology: Prof. Li has a keen interest in developing predictive models to optimize drug efficacy and safety, leveraging mathematical frameworks to personalize treatment.

Genetic Pharmacology: His research focuses on exploring genetic factors that influence drug metabolism and efficacy, aiming to enhance personalized medicine approaches.

Prof. Li has successfully led over ten major projects, including initiatives funded by the Ministry of Science and Technology, the National Natural Science Foundation, and the Beijing Science and Technology Plan. These projects address critical areas like drug delivery systems, personalized pharmacotherapy, and genetic determinants of drug response.

🖋️ Publication Achievements:

Prof. Li’s academic rigor is evident in his extensive publication record, with over 50 articles in Q1 journals such as Nano Letters, Acta Pharmacologica Sinica, and Phytomedicine. His works have been cited more than 1000 times, and he holds an impressive H-index of 20, reflecting his impact on the scientific community. His publications explore innovative drug delivery systems, genetic biomarkers, and clinical pharmacokinetics, contributing significantly to global pharmacological advancements.

🏆 Scholarships and Awards:

Prof. Li has received numerous accolades for his contributions:

Servier Young Hospital Pharmacy Award, China Pharmaceutical Society
Outstanding Pharmacist Award, Beijing Pharmaceutical Society
Recognized for Outstanding Papers and groundbreaking research, reflecting his excellence in clinical pharmacy and translational research.

🧑‍🔬 Professional Associations and Editorial Roles:

Prof. Li is actively involved in professional organizations, including the Chinese Pharmacological Society and the China Pharmaceutical Education Association. He serves as an Editorial Board Member for journals such as China Hospital Pharmacy Evaluation and Analysis and Chinese Pharmacy, ensuring the dissemination of high-quality research.

As a Reviewer for prestigious journals like Biomaterials and Clin Transl Med, he evaluates cutting-edge studies in pharmacology, bioinformatics, and materials science, further contributing to his field’s knowledge base.

💻 Bioinformatics and Laboratory Experience:

Prof. Li integrates bioinformatics tools into his research to analyze complex datasets and identify genetic markers associated with drug response. His laboratory is equipped with advanced technologies for pharmacokinetic modeling, epigenetic profiling, and drug formulation analysis, enabling groundbreaking discoveries.

🎓 Training, Workshops, and Oral Presentations:

Prof. Li regularly participates in international conferences, presenting his research findings and engaging with global experts. His oral presentations at prestigious forums highlight advancements in therapeutic drug monitoring (TDM), anesthesiology pharmacy, and intravenous preparation management, solidifying his reputation as a thought leader.

✅ Tasks Completed as a Researcher:

Prof. Li has successfully completed tasks ranging from designing clinical trials to publishing high-impact research. His ability to translate laboratory findings into practical solutions for patient care exemplifies his commitment to improving healthcare outcomes.

🌟 Success Factors and Key Contributions:

Prof. Li’s success stems from his:

Collaborative approach in multidisciplinary projects
Innovative methodologies in drug evaluation and genetic research
Dedication to mentoring young professionals and fostering academic growth

🔬 Ongoing Research Projects:

His current projects delve into:

Advanced drug delivery systems to enhance treatment efficacy
Epigenetic influences on pharmacodynamics
Personalized medicine approaches using genetic profiling

🔍 Conclusion:

Prof. Li Xingang is a distinguished leader in the field of pharmacology, whose contributions span clinical excellence, innovative research, and impactful publications. His work in quantitative and genetic pharmacology, combined with his dedication to mentoring and professional engagement, sets him apart as a visionary in healthcare. His achievements and ongoing endeavors continue to shape the future of precision medicine and pharmacological sciences.

Top Notable Publications:

1. Immune-Related Colitis Induced by Camrelizumab: A Case Report

Authors: Xingang Li

Journal: Journal of Inflammation Research

Year: 2023

2. Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice-

Year: 2023

3. Association of Alcohol Drinking and Helicobacter pylori Infection: A Meta-analysis

Authors: Xingang Li

Journal: Journal of Clinical Gastroenterology

Year: 2023

4. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice

Year: 2022

5. Association between GNAQ Gene DNA Methylation and Vascular Recurrence in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

Authors: Xingang Li

Journal: Cerebrovascular Diseases (Basel, Switzerland)

Year: 2022

6. Impact of Azithromycin on Forsythiaside Pharmacokinetics in Rats: A Population Modeling Method

Authors: Xingang Li

Journal: Current Medical Science

Year: 2022

7. Docetaxel population pharmacokinetic modelling and simulation in Chinese cancer patients

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

8. Development of a multivariable clinical prediction model for liposomal doxorubicin-induced cardiotoxicity in adult breast cancer patients: A retrospective multicenter study

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

9. Population pharmacokinetics of methotrexate in pediatric patients with acute lymphoblastic leukemia and malignant lymphoma

Authors: Xingang Li

Journal: Xenobiotica

Year: 2022

10. The clinical population pharmacokinetics, metabolomics, and therapeutic analysis of alkaloids from Alstonia scholaris leaves in acute bronchitis patients

Authors: Xingang Li

Journal: Phytomedicine

Year: 2022

Fulin Liu | Cardiology | Best Researcher Award

Published on 12/12/202412/12/2024 by Cardiology and Cardiovascular Medicine

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]

Cancan Zhou | Hepatic toxicology | Best Research Award

Published on 12/12/202412/12/2024 by Cardiology and Cardiovascular Medicine

Prof. Cancan Zhou | Hepatic toxicology | Best Research Award

Prof. Cancan Zhou, Shanghai Tenth People’s Hospital, China

Prof. Cancan Zhou is a distinguished researcher at the Department of Pharmacy, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, China. He is an active member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee. Prof. Zhou has led a youth project under the National Natural Science Foundation of China, funded by the Shanghai Sailing Program, and has authored over 10 SCI-indexed papers as the first or corresponding author. Her expertise focuses on hepatic toxicology, drug safety, and advanced pharmacological research.

Profile:

Scopus Profile

📘 EARLY ACADEMIC PURSUITS:

The Department of Pharmacy at Shanghai Tenth People’s Hospital, affiliated with Tongji University School of Medicine, Shanghai, China, serves as a cornerstone for advanced clinical pharmaceutical education and research. With a strong emphasis on evidence-based practices and innovation, the academic foundation was laid through rigorous training in drug evaluation, pharmaceutical management, and patient-centric care. This foundation has enabled significant advancements in the field of clinical pharmacy.

💼 PROFESSIONAL ENDEAVORS:

As a Member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee, the individual plays a pivotal role in shaping clinical pharmaceutical policies and practices. These roles underscore a dedication to improving healthcare systems, advancing drug evaluation protocols, and ensuring the highest standards of pharmaceutical care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Hepatic toxicology :

A highlight of this career is the successful leadership of a youth project under the National Natural Science Foundation of China, supported by the prestigious Shanghai Sailing Program. The research primarily focuses on:

Clinical Drug Evaluation 🩺
Innovative Pharmaceutical Management Strategies 📈
Advancing Patient-Centered Therapies 🤝

This work has had a transformative effect on improving drug safety, efficacy, and accessibility in clinical settings.

🌟 IMPACT AND INFLUENCE:

With more than 10 SCI-indexed publications as the first or corresponding author, the individual’s research contributions have significantly influenced both academic discussions and practical applications in the pharmaceutical sciences. These publications have enhanced the understanding of clinical drug evaluation processes and established benchmarks for excellence in research methodologies.

📖 ACADEMIC CITES:

The widespread citation of these publications reflects their impact on the global scientific community. The work has inspired new research, informed clinical guidelines, and contributed to the development of innovative therapeutic strategies. These achievements highlight the individual’s reputation as a thought leader in pharmaceutical sciences.

🔮 LEGACY AND FUTURE CONTRIBUTIONS:

This career reflects a legacy of excellence, blending cutting-edge research with impactful professional service. Moving forward, the focus is expected to center on:

Integrating Artificial Intelligence into Drug Evaluation 🤖
Developing Sustainable Healthcare Practices 🌱
Expanding International Collaborations in Clinical Research 🌍

These contributions aim to enhance healthcare outcomes, streamline pharmaceutical processes, and pave the way for next-generation drug development and management.

💡 OTHER IMPORTANT TOPICS:

🏆 LEADERSHIP IN CLINICAL PHARMACEUTICAL COMMITTEES

Active participation in key committees showcases exemplary leadership and the ability to influence policy decisions that shape the future of clinical pharmacy in Shanghai and beyond.

📈 SUCCESS IN YOUTH PROJECTS

The youth project, supported by competitive funding, highlights the individual’s capacity to lead high-impact research. This success demonstrates both academic merit and the ability to deliver results in fast-evolving scientific domains.

👨‍🏫 MENTORSHIP AND EDUCATION

As part of Tongji University School of Medicine, the individual likely contributes to training the next generation of clinical pharmacists, fostering innovation, and promoting ethical and evidence-based practices.

🌍 VISION FOR GLOBAL PHARMACEUTICAL INTEGRATION

Future aspirations include strengthening cross-border collaborations to harmonize pharmaceutical standards, improve global drug accessibility, and contribute to sustainable healthcare practices worldwide.

✨ CONCLUSION:

The professional journey outlined reflects a remarkable blend of academic excellence, impactful research, and leadership in clinical pharmacy. With a clear vision for future contributions, this profile is set to continue driving innovation, improving patient care, and leaving a lasting legacy in pharmaceutical sciences.

TOP NOTABLE PUBLICATIONS:

STING Signaling Contributes to Methotrexate-Induced Liver Injury by Regulating Ferroptosis in Mice

Authors: Wang, H.-F.; He, Y.-Q.; Ke, Z.; Zhou, C.-C.; Xu, J.-S.

Journal: Ecotoxicology and Environmental Safety

Year: 2024

Natural Products for the Treatment of Chemotherapy-Related Cognitive Impairment and Prospects of Nose-to-Brain Drug Delivery

Authors: He, Y.-Q.; Zhou, C.-C.; Jiang, S.-G.; Tao, X.; Chen, W.-S.

Journal: Frontiers in Pharmacology

Year: 2024

Ursodeoxycholic Acid Alleviates Sepsis-Induced Lung Injury by Blocking PANoptosis via STING Pathway

Authors: He, Y.-Q.; Deng, J.-L.; Zhou, C.-C.; Tao, X.; Chen, W.-S.

Journal: International Immunopharmacology

Year: 2023

Long Survival in a Pancreatic Carcinoma Patient with Multi-Organ Toxicities After Sintilimab Treatment: A Case Report

Authors: Ni, C.-X.; Zhao, Y.; Qian, H.; Li, D.-J.; Xu, Q.

Journal: Frontiers in Pharmacology

Year: 2023

Clinical Features of Omicron SARS-CoV-2 Variants Infection Associated with Co-Infection and ICU-Acquired Infection in ICU Patients

Authors: Li, D.-J.; Zhou, C.-C.; Huang, F.; Shen, F.-M.; Li, Y.-C.

Journal: Frontiers in Public Health

Year: 2023

Zinc Supplementation Ameliorates Sorafenib-Induced Cognitive Impairment Through ROS/JNK Signaling Pathway

Authors: Zhou, C.-C.; He, Y.-Q.; Qiu, Y.-S.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2023

Exerkine Fibronectin Type-III Domain-Containing Protein 5/Irisin-Enriched Extracellular Vesicles Delay Vascular Ageing by Increasing SIRT6 Stability

Authors: Chi, C.; Fu, H.; Li, Y.-H.; Li, D.-J.; Wang, P.

Journal: European Heart Journal

Year: 2022

Activating α7nAChR Ameliorates Abdominal Aortic Aneurysm Through Inhibiting Pyroptosis Mediated by NLRP3 Inflammasome

Authors: Fu, H.; Shen, Q.-R.; Zhao, Y.; Liang, G.; Shen, F.-M.

Journal: Acta Pharmacologica Sinica

Year: 2022

Lead Exposure in Developmental Ages Promotes Aβ Accumulation by Disturbing Aβ Transportation in Blood-Cerebrospinal Fluid Barrier/Blood–Brain Barriers and Impairing Aβ Clearance in the Liver

Authors: Zhou, C.-C.; Wang, X.-J.; Li, Z.-C.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2022

Abdominal Aortic Aneurysm: Pathological Mechanism and Animal Model

Authors: Fu, H.; Zhou, C.; Li, D.; Shen, F.

Journal: Acta Academiae Medicinae Sinicae

Year: 2022

Yumei Li | Pediatric Cardiology | Best Researcher Award

Published on 09/12/202411/12/2024 by Cardiology and Cardiovascular Medicine

Prof.Yumei Li | Pediatric Cardiology | Best Researcher Award

Prof. Yumei Li, The First Hospital of Jilin University, China.

Yumei Li is the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. A renowned leader in Pediatric Critical Care Medicine, she founded the largest and most advanced pediatric critical care unit in Jilin Province. With over 31 years of experience, Professor Li has led 50 research projects and published 130 papers, including 45 SCI-indexed articles. She has mentored doctoral students, contributed to eight key textbooks, and secured nearly 4 million yuan in research funding. Her work in pediatric liver transplantation and life support technology has driven innovation and saved countless lives.

Author Profile:

Scopus Profile

Summary of Suitability for Best Researcher Award

Dr. Yumei Li, Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University, is an exemplary candidate for the Best Researcher Award. With over 31 years of experience, Dr. Li has made pioneering contributions in pediatric critical care, particularly in pediatric liver transplantation and extracorporeal life support technologies, transforming clinical care standards in Jilin Province.Her impressive research portfolio includes leading 50 national and provincial projects, securing nearly 4 million yuan in research funding. Dr. Li has published 130 research papers, with 45 indexed in SCI journals, reflecting her significant global impact. Additionally, her academic influence is demonstrated through 16 teaching grants, authorship of 8 major textbooks, and supervision of 21 research scholars (15 graduated, 6 ongoing).

Education:

Yumei Li holds a doctoral degree in Pediatrics, showcasing her strong academic foundation and commitment to advancing medical knowledge. As a professor and doctoral supervisor, she has dedicated nearly 30 years to pediatric education and research. Her expertise spans pediatric critical care, with significant contributions to clinical advancements and medical education. She has played a key role in developing pediatric textbooks and teaching materials, serving as an editorial board member for several publications. Her passion for education and mentorship has shaped future pediatric specialists, solidifying her reputation as a distinguished educator and leader in the field of Pediatrics.

Professional Experience:

Yumei Li has over 31 years of professional experience in Pediatrics and Pediatric Critical Care Medicine. She currently serves as the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. As the founder of Pediatric Critical Care Medicine in Jilin Province, she has played a pivotal role in developing the region’s most advanced pediatric critical care unit. Her expertise spans pediatric liver transplantation and extracorporeal life support technology. Additionally, she is a professor, doctoral supervisor, and an influential contributor to medical education and clinical innovation

🌍Research Contributions:

Award and Honors:

Yumei Li has received 16 awards and honors recognizing her outstanding contributions to pediatric critical care and medical research. As the founder of the Pediatric Critical Care Medicine Department in Jilin Province, she has been honored for advancing pediatric liver transplantation and extracorporeal life support technology. Her leadership and dedication have earned her numerous accolades for excellence in clinical practice, teaching, and research. Professor Li’s impactful contributions include leading 50 research projects and publishing 130 papers, which have significantly influenced pediatric healthcare. These achievements highlight her commitment to innovation, education, and improving patient outcomes, solidifying her reputation as a distinguished medical professional.

Conclusion:

Professor Yumei Li has made outstanding contributions to the field of Pediatric Critical Care Medicine through her exceptional leadership, research, and clinical expertise. With over 31 years of experience, she has established the largest pediatric critical care unit in Jilin Province, significantly advancing pediatric liver transplantation and extracorporeal life support technologies. Her impressive research portfolio, including 50 funded projects and 130 publications with 45 SCI-indexed papers, reflects her commitment to innovation and academic excellence. Professor Li’s dedication to education, mentorship, and technological advancements highlights her as a pioneering figure, making her a deserving candidate for the Best Researcher Award.

Publication Top Notes:

📄 “Comprehensive review of indicators and techniques for optical mapping of intracellular calcium ions” – Cerebral Cortex, 2024, 34(8), bhae346 | Cited: 0

🧒 “Children with severe neurological symptoms associated with SARS-CoV-2 infection during Omicron pandemic in China” – Pediatric Research, 2024, 95(4), pp. 1088–1094 | Cited: 0

🏥 “Association between BNP and all-cause mortality in critically ill children: a cohort study” – Pediatric Research, 2024 | Cited: 0

🦠 “Biliary atresia: the role of gut microbiome, and microbial metabolites” – Frontiers in Cellular and Infection Microbiology, 2024, 14, 1411843 | Cited: 0

🍊 “Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications” – Frontiers in Pharmacology, 2024, 15, 1354809 | Cited: 4

🚨 “Demographics and Clinical Characteristics Assessment of Severe Acute Toxic Ingestions in Pediatric Patients: A Single-Center Study in Jilin Province of China” – Pediatric Emergency Care, 2023, 39(12), pp. 957–962 | Cited: 0

🧪 “Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor” – Materials Today Bio, 2023, 23, 100796 | Cited: 6

🧠 “Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature” – Acta Neurologica Belgica, 2023, 123(5), pp. 1663–1678 | Cited: 0

⚛️ “One-Component Artificial Gustatory System Based on Hydrogen-Bond Organic Framework for Discrimination of Versatile Analytes” – Advanced Functional Materials, 2023, 33(24), 2300091 | Cited: 22

🔄 “Therapeutic plasma exchange in anti-N-methyl-D-aspartate receptor encephalitis” – Therapeutic Apheresis and Dialysis, 2023, 27(2), pp. 197–206 | Cited: 0

XIngcheng Yi | Myocardial tissue repair | Best Researcher Award

Published on 28/11/202428/11/2024 by Cardiology and Cardiovascular Medicine

Dr. XIngcheng Yi | Myocardial tissue repair | Best Researcher Award

Dr. XIngcheng Yi, The First Hospital of Jilin University, China

🌟Profile Overview:

Dr. Xingcheng Yi is a distinguished medical professional at The First Hospital of Jilin University, China, specializing in cutting-edge clinical and translational research. With a strong focus on advancing patient care, Dr. Yi’s expertise spans cardiovascular medicine, oncology, and innovative therapeutic approaches. A dedicated scholar and practitioner, Dr. Yi is actively involved in groundbreaking studies, contributing to the global medical community through peer-reviewed publications and collaborative projects. Known for integrating clinical insights with advanced research, Dr. Yi’s work continues to impact healthcare practices and improve outcomes for patients worldwide.

Profile:

Scopus Profile

🎓Current Position:

Currently serving as a lead researcher in Cell Biology, my work focuses on innovative therapeutic strategies for myocardial tissue repair. Leveraging expertise in computational biology, I aim to bridge experimental and computational sciences to drive impactful discoveries in cardiovascular health.

📚Academic Background:

Earned a Ph.D. in Cell Biology, with a thesis focused on molecular interaction networks in myocardial injury.
Prior to this, completed a Master’s in Biological Sciences, specializing in cellular mechanisms and computational applications.

📝Publications Achievements:

Publications: Authored 11 peer-reviewed journal articles, indexed in SCI and Scopus, spanning myocardial repair, single-cell transcriptomics, and graph deep learning.
Books: Published 11 books with ISBN registration, contributing to knowledge dissemination in cell biology and computational techniques.
Citations: Achieved a citation index of 18, demonstrating the growing influence of my research in the academic community.
Recognized for a recent impactful study on Ginsenoside Rb1 and PRDX6 in mitigating myocardial injury.

🔬Ongoing Research Projects:

Current Projects: Actively involved in three research projects, focusing on:

Synergistic Therapies: Examining natural compounds and molecular interactions for cardiac protection.
Transcriptomics: Exploring gene expression changes linked to tissue repair and cellular stress responses.
Graph-Based Models: Developing AI-based models to predict molecular interaction networks and their biological implications.

Collaborations: Engaged in interdisciplinary collaborations with computational scientists and clinical researchers to validate models in vivo.

🔍Research Interests:

Areas of expertise and passion include:

Myocardial Tissue Repair: Exploring cellular mechanisms to improve heart regeneration.
Single-Cell Transcriptomics: Unraveling cellular diversity and gene expression.
Graph Deep Learning: Applying cutting-edge computational tools for network analysis.
Bioinformatics: Leveraging data-driven approaches to solve biological challenges.

🏆Awards and Scholarships:

Recipient of multiple awards for research excellence, including the prestigious Best Researcher Award for groundbreaking work in myocardial repair.
Secured competitive scholarships during doctoral studies, highlighting academic rigor and potential.

🎤Professional Associations:

Active member of professional societies like the Society for Computational Biology and the American Heart Association, contributing to global discussions on translational research.

🎓Training & Workshops:

Participated in numerous workshops on advanced computational techniques, transcriptomics, and bioinformatics.
Conducted training sessions for peers, fostering skills in RNA-seq analysis and molecular modeling.

🧪Laboratory Experience and Publications:

Proficient in wet lab techniques such as immunohistochemistry, PCR, and cell culture, complemented by computational methods like network analysis and deep learning models.
Authored comprehensive reports and proposals that secured funding for cutting-edge research.

🛠️Tasks Completed as a Researcher:

Designed and executed experiments involving RNA sequencing and gene expression profiling.
Supervised lab teams in handling complex protocols for tissue repair studies.
Published high-impact manuscripts, showcasing methodological rigor and innovative findings.

🎤Oral Presentations:

Delivered over 15 oral presentations at national and international conferences, including keynote sessions on myocardial repair strategies.
Topics included novel therapeutic combinations and advancements in single-cell analysis.

🌟Success Factors:

My success stems from a combination of interdisciplinary expertise, strong analytical skills, and an unwavering commitment to advancing cardiovascular science.
Emphasis on collaboration ensures that my research remains globally relevant and impactful.

🌍Conclusion:

My journey as a researcher is defined by a relentless drive to innovate in myocardial tissue repair and computational biology. By integrating biological insights with computational tools, I aim to pave the way for new therapeutic solutions that save lives. From groundbreaking publications to collaborative projects, my work continues to contribute meaningfully to science and society.

Top Notable Publications:

Article: Hypoxia adaptation mechanism in rats’ peripheral auditory system in high altitude migration: a time series transcriptome analysis
Authors: Wang, L., Yi, X., Zhou, Y., Su, X., Wang, P.
Year: 2024
Journal: Scientific Reports
Citations: 0

Letter: Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study
Authors: Zhang, Y., Liang, X., Xu, W., Dai, Y., Jin, F.
Year: 2024
Journal: Journal of Hematology and Oncology
Citations: 1

Article: Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis
Authors: Xu, W., Liang, X., Liu, S., Dai, Y., Jin, F.
Year: 2024
Journal: Clinical Medicine, Journal of the Royal College of Physicians of London
Citations: 0

Article: Plumbagin induces G2/M arrest and apoptosis and ferroptosis via ROS/p38 MAPK pathway in human osteosarcoma cells
Authors: Li, J., Gao, H., Wang, P., Zhang, Y., Li, S.
Year: 2024
Journal: Alexandria Engineering Journal
Citations: 1

Article: MediDRNet: Tackling category imbalance in diabetic retinopathy classification with dual-branch learning and prototypical contrastive learning
Authors: Teng, S., Wang, B., Yang, F., Zhang, X., Sun, Y.
Year: 2024
Journal: Computer Methods and Programs in Biomedicine
Citations: 0

Article in Press: Synergistic effects of ginsenoside Rb1 and peroxiredoxin 6 in enhancing myocardial injury treatment through anti-inflammatory, anti-oxidative, and anti-apoptotic mechanisms
Authors: Mu, R., Li, Y., Cui, Y., Guo, X., Yi, X.
Year: 2024
Journal: Journal of Ginseng Research
Citations: 0

Letter: More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
Authors: Tian, M., Liang, X., Xu, W., Dai, Y., Jin, F.
Year: 2023
Journal: Annals of Hematology
Citations: 0

Letter: Dynamic monitoring of minimal residual disease in newly-diagnosed multiple myeloma
Authors: Yang, P., Xu, W., Liang, X., Dai, Y., Jin, F.
Year: 2023
Journal: American Journal of Hematology
Citations: 3

Article: Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma
Authors: Yang, P., Chen, H., Liang, X., Dai, Y., Jin, F.
Year: 2023
Journal: American Journal of Hematology
Citations: 7

Article: Research on the pathological mechanism of rectal adenocarcinoma based on DNA methylation
Authors: Pan, X., Yi, X., Lan, M., Zhou, F., Wu, W.
Year: 2023
Journal: Medicine (United States)
Citations: 2

Hamed Afkhami | Breast cancer (BC) | Best Researcher Award

Published on 21/11/202421/11/2024 by Cardiology and Cardiovascular Medicine

Dr. Hamed Afkhami | Breast cancer (BC) | Best Researcher Award

Dr. Hamed Afkhami, Qom University of Medical Sciences, Iran

🌟Bioinformatics:

Dr. Hamed Afkhami is a skilled microbiologist and educator at Qom University of Medical Sciences, Iran. He holds a Doctorate in Medical Bacteriology from Shahid Beheshti University of Medical Sciences and specializes in antimicrobial research, stem cell therapies, and nanotechnology applications in microbiology. With over eight years of teaching experience and numerous publications, patents, and congress presentations, Dr. Afkhami is a recognized expert in his field. His work bridges academic excellence and innovative research, contributing significantly to medical science advancements.

Profile:

Scopus Profile

Google Scholar Profile

🏥Current Position and Roles:

Hamed Afkhami is a distinguished professional in the field of medical microbiology and bacteriology. He is currently a professor at Qom Azad University and also serves as the quality control manager of the microbiology department at Kamkar Hospital, Qom Province. His role involves ensuring laboratory excellence, supervising diagnostic workflows, and driving research into microbial pathogens.

🎓Academic Background:

Hamed’s educational journey reflects exceptional dedication:

Specialized Doctorate in Medical Bacteriology
Shahid University of Medical Sciences, Tehran (1398–1403), GPA: 18/30
Focus: Advanced bacteriology techniques, antimicrobial properties of nanostructures.
Master’s in Medical Microbiology
Iran University of Medical Sciences (1394–1397), GPA: 17/25
Thesis: Antimicrobial properties of graphene-alginate quantum dot nanocomposites.
Bachelor’s in Microbiology
Qom University of Medical Sciences (1389–1393), GPA: 25.17
Comprehensive focus on bacteriology, virology, and parasitology.

📄🖋️Publication Achievements:

Hamed has an extensive publication portfolio, including three English books published internationally on platforms like Noor, Scholar, and Amazon. Notable works include:

Overview of Amyotrophic Lateral Sclerosis
Manual Endoscopic Device for Human Airway Blockages
Antibacterial Applications of Hydrogel Scaffolds

🌍🧪Research Articles:

His scholarly contributions focus on antimicrobial nanocomposites, stem-cell encapsulation in hydrogels, and biofilm-resistant materials. His articles have been featured in prestigious journals and presented at leading congresses like the 21st International Microbiology Congress of Iran. 🌍🧪

🔬📝Ongoing Research:

Hamed’s current research includes:

Investigating antimicrobial properties of Gelatin-GQD nanocomposites on burn infections caused by Pseudomonas aeruginosa.
Developing biofilm-resistant wound dressings utilizing mesenchymal stem cells in collagen-fibrin hydrogel scaffolds.
Exploring antimicrobial peptide applications for combatting Peptostreptococcus anaerobius infections in mice.

🔎🧬Research Interests:

Hamed’s diverse research interests encompass:

Antimicrobial resistance mechanisms.
Tissue engineering using nanostructured materials.
Viral infections and the role of probiotics in disease prevention.
Innovative applications in stem cell encapsulation and biofilm inhibition.

🏛️✅Professional Associations & Tasks Completed:

Member of the Executive Committee for multiple scientific congresses, including the 8th, 9th, and 10th Laboratory and Clinical Congresses.
Conducted flow cytometry and real-time PCR workshops, emphasizing hands-on skills.
Supervised students for national rankings in medical sciences and bacteriology. 🌟👩‍🎓👨‍🎓

🏫🛠️Training & Workshops Conducted:

ISO 15189 Workshop: Quality management in medical laboratories.
Essay Writing Workshops: At Azad University of Qom, fostering academic excellence in research.
PCR Techniques & Applications: Hands-on training in advanced molecular diagnostics.

🚀✨Success Factors:

Hamed attributes his professional success to:

Unwavering curiosity and dedication to microbial research.
Strong mentorship from top researchers like Dr. Kamili and Dr. Davalit.
Integration of innovative techniques such as electrospinning and stem cell-based therapy.

🧪📊Publications & Laboratory Experience:

Hamed has extensive laboratory experience, including:

Fabrication of tissue engineering scaffolds for wound healing.
Development of antibacterial hydrogels with cutting-edge nanomaterials.
Proficiency in diagnostic techniques such as antibiogram tests, ELISA, and flow cytometry.

🎤🔬Oral Presentations & Patents:

Hamed has delivered numerous oral presentations at congresses and holds three patents, including:

A multi-channel syringe for drug delivery.
An innovative antimicrobial dressing.
A manual endoscopic device for airway clearance.

Citations:

Citations – 753

i10-index – 2

🌟📜Conclusion: A Remarkable Journey in Microbiology

Hamed Afkhami exemplifies excellence in medical microbiology, with a balance of teaching, research, and clinical expertise. His contributions to nanomaterials, antimicrobial resistance, and bioengineering have advanced the field, earning recognition at national and international levels. His commitment to mentoring, innovation, and community service makes him a cornerstone of microbiological research and education. 🌍🔬

Top Notable Publications:

Investigation of CST7 and hsa-miR-4793-5p gene expression in breast cancer
Authors: Kalaki, N.S., Ahmadzadeh, M., Dehghan, M., Davoudi, S., Afkhami, H.
Year: 2024
Journal: Biochemistry and Biophysics Reports
Volume: 40
Article ID: 101863
Citations: 0

Mechanisms of resistance and decreased susceptibility to azithromycin in Shigella
Authors: Ghalavand, Z., Behruznia, P., Kodori, M., Neamati, F., Poornaki, S.M.
Year: 2024
Journal: Gene Reports
Volume: 37
Article ID: 102011
Citations: 0

Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Authors: Yarahmadi, A., Zare, M., Aghayari, M., Afkhami, H., Jafari, G.A.
Year: 2024
Journal: Cell Communication and Signaling
Volume: 22 (1)
Article ID: 239
Citations: 0

Corrigendum to “Potential antibacterial activity and healing effect of topical administration of bone marrow and adipose mesenchymal stem cells encapsulated in collagen-fibrin hydrogel scaffold on full-thickness burn wound infection caused by Pseudomonas aeruginosa”
Authors: Mirshekar, M., Afkhami, H., Razavi, S., Motaghinejad, M., Karimi, R.
Year: 2024
Journal: Burns
Volume: 50 (8)
Pages: 2141
Citations: 0

New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Authors: Farokhi, S., Razavi, Z.-S., Mavaei, M., Afkhami, H., Sardarabadi, H.
Year: 2024
Journal: Discover Applied Sciences
Volume: 6 (8)
Article ID: 411
Citations: 4

Bactericidal Activity of Serum by Brucella Abortus RB51 Outer Membrane Protein’s Combined by Brucella Abortus S99 Lipopolysaccharide Induction
Authors: Sisakht, B.H., Khaledi, M., Afkhami, H., Fathi, J., Sadati, M.S.
Year: 2024
Journal: Avicenna Journal of Medical Biotechnology
Volume: 16 (3)
Pages: 187–192
Citations: 0

Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection
Authors: Hassan Kalantar Neyestanaki, M., Gholizadeh, O., Hosseini Tabatabaie, F., Afkhami, H., Sedighi, S.
Year: 2024
Journal: VirusDisease
Volume: 35 (2)
Pages: 342–356
Citations: 0

Materials based on biodegradable polymers chitosan/gelatin: a review of potential applications
Authors: Yarahmadi, A., Dousti, B., Karami-Khorramabadi, M., Afkhami, H.
Year: 2024
Journal: Frontiers in Bioengineering and Biotechnology
Volume: 12
Article ID: 1397668
Citations: 2

Applications of mesenchymal stem cell-exosome components in wound infection healing: new insights
Authors: Fakouri, A., Razavi, Z.-S., Mohammed, A.T., Afkhami, H., Hooshiar, M.H.
Year: 2024
Journal: Burns and Trauma
Volume: 12
Article ID: tkae021
Citations: 8

Continue reading “Hamed Afkhami | Breast cancer (BC) | Best Researcher Award” →

Hayat Ullah | Pharmacology | Best Researcher Award

Published on 14/11/202414/11/2024 by Cardiology and Cardiovascular Medicine

Dr. Hayat Ullah | Pharmacology | Best Researcher Award

Dr. Hayat Ullah, University of Okara, Pakistan

🌟Bioinformatics:

Dr. Hayat Ullah is a dedicated and accomplished organic chemist with a passion for advancing synthetic organic chemistry, particularly in the synthesis of bioactive compounds. His research interests extend into medicinal chemistry and the discovery of compounds with potential therapeutic uses. He has garnered recognition for his contributions to science and education in Pakistan and internationally, alongside a proven record of academic excellence and professional impact.

Profile:

Scopus Profile

Orcid Profile

Google Scholar Profile

🏥Current Position and Roles:

Dr. Hayat Ullah currently serves as a Visiting Assistant Professor in the Department of Chemistry at the University of Okara, Pakistan. His role involves lecturing in various fields of organic chemistry, mentoring students, and contributing to curriculum development. He has also previously held a position as an Assistant Professor (IPFP) at the same institution, where he was integral in course planning, student engagement, and guiding research initiatives.

🎓Academic Background:

Dr. Hayat Ullah‘s academic journey in chemistry is both extensive and focused. He completed his Ph.D. in Organic Chemistry (2014-2018) at Hazara University, Pakistan, where he explored the “Synthesis and Biological Evaluation of Thiazole, Oxadiazole, and Indole Derivatives.” Prior to this, he pursued an M.Phil. in Organic Chemistry (2012-2014) at Hazara University, focusing on the biological evaluation of thiazole derivatives. His early academic milestones include an M.Sc. in Organic Chemistry from Kohat University of Science & Technology (2005-2007) and a B.Sc. from the University of Peshawar, Pakistan (2003-2005), both achieved with distinction. Additionally, he earned a Bachelor of Education (B.Ed.) from the University of Peshawar (2009-2010), which equipped him with essential teaching skills.

🧪🔬Research Interests and Ongoing Research:

Dr. Ullah’s research focuses on bioactive compound synthesis, particularly within synthetic organic chemistry, and exploring asymmetric synthesis. He is engaged in developing innovative methodologies aimed at discovering new molecules with potential applications as anti-Alzheimer’s agents. His current project, funded with PKR 1,000,000, is a focused initiative targeting the development of acetylcholinesterase and butyrylcholinesterase inhibitors using indole-bearing oxadiazole scaffolds, which holds promise in the field of Alzheimer’s research.

📚🏆Publications and Achievements:

Throughout his career, Dr. Ullah has authored multiple scientific publications in prestigious journals, detailing his findings on bioactive compounds and their medicinal applications. His work has been well-received within the academic community, earning him the designation of HEC Approved Supervisor in 2020 by Pakistan’s Higher Education Commission (HEC). He also holds an Associate Fellowship from Advance HE, UK (2022), highlighting his contributions to higher education and pedagogy.

Notable Publications:

Articles focused on synthetic methodologies and biological evaluations of compounds.
Research outputs that align with his goals of contributing to medicinal chemistry.

📈🛠️Training & Workshops:

Dr. Ullah has pursued extensive professional development through programs by Pakistan’s Higher Education Commission, including:

Startup Research Grant Program (NAHE), 2021: This grant supports emerging researchers in building a foundation for their scientific endeavors.
National Faculty Development Program (NAHE), 2020: A comprehensive training initiative that improved his pedagogical and research skills.
Fundamentals of Project Management (NAHE), 2021: Focused on enhancing project management competencies essential for academic research.
ACS Reviewer Lab, American Chemical Society, 2020: International training on peer-review techniques, sharpening his editorial skills in scientific publishing.

🎓📖Courses Taught:

Dr. Ullah’s teaching portfolio encompasses several specialized courses for undergraduate and postgraduate students. His courses include:

Organic Spectroscopy
Heterocyclic Chemistry
Fuel Chemistry
Research Methodology
Organic Synthesis
Environmental Chemistry

These courses reflect his broad expertise in organic chemistry and his commitment to providing a comprehensive education to his students.

🏅🎖️Scholarships and Awards:

Dr. Ullah has received numerous accolades, including grants, fellowships, and recognitions. Some of his awards are:

Associate Fellowship, Advance HE, UK (2022)
HEC Approved Supervisor (2020)
Startup Research Grant Program (2021)
National Faculty Development Program (2020)

These awards underscore his dedication to both teaching and research excellence in the field of organic chemistry.

🌍🎤Professional Associations and Presentations:

As a respected member of the academic community, Dr. Ullah has actively contributed to professional associations and academic conferences, sharing his research findings and engaging with peers. His involvement includes:

Oral Presentations: Delivered at national and international forums, particularly on synthetic organic chemistry.
Professional Associations: Regular participation in chemistry societies, fostering collaboration and knowledge-sharing with fellow researchers.

Dr. Ullah’s hands-on experience in organic chemistry laboratories has been instrumental in his research on bioactive compounds. His laboratory skills include organic synthesis techniques, spectroscopic analysis, and bioactivity assays. This technical proficiency enables him to undertake complex synthetic chemistry projects and train students in laboratory best practices.

Citations:

Citations: 3289

h-index: 35

i10-index: 64

🌟Conclusion: Success Factors and Impact:

Dr. Hayat Ullah’s career exemplifies a commitment to scientific advancement and education in organic chemistry. His success can be attributed to:

Academic Excellence: A solid educational foundation in organic chemistry and continuous professional development.
Research Contributions: Focused research in bioactive compounds, contributing to advancements in medicinal chemistry.
Teaching and Mentorship: A diverse teaching portfolio, inspiring future scientists and fostering a supportive learning environment.
Professional Recognition: Acknowledged through awards and certifications, highlighting his dedication to his field.

Through his teaching, research, and professional development, Dr. Ullah has made significant contributions to the field of chemistry, particularly in Pakistan’s academic landscape, and is poised to continue impacting the realms of organic and medicinal chemistry.

Top Notable Publications:

Nadeem, M.S., Hayat, S., Rahim, F., Iftikhar, S., Muhammad, K. (2025). Synthesis, biological evaluation, molecular docking and dynamic simulation of novel benzofuran derivatives as potential agents against Alzheimer’s disease. Journal of Molecular Structure, 1322, 140279.

Iqbal, T., Khan, S., Rahim, F., Alzahrani, A.Y.A., Alraih, A.M. (2025). Insights into the role of potent thiadiazole-based Schiff base derivatives in targeting type-II diabetes: A combine in-vitro and in-silico approaches. Journal of Molecular Structure, 1321, 140000.

Umar, A., Khan, M.S., Wajid, M., Ullah, H. (2024). Biocompatibility, antimicrobial efficacy, and therapeutic potential of cobalt carbonate nanoparticles in wound healing, sex hormones, and metabolic regulation in diabetic albino mice. Biochemical and Biophysical Research Communications, 734, 150773.

Alzahrani, A.Y.A., Ullah, H., Rahim, F., Iqbal, N., Nawaz, F. (2024). Synthesis, biological evaluation and in silico molecular modeling studies of chloro substituted bis-indole containing benzohydrazide analogues as potential anti-diabetic and anti-Alzheimer’s agents. Journal of Molecular Structure, 1316, 138908.

Ullah, H., Uddin, I., Ali, H.Z., Iqbal, R., Nabi, M. (2024). A promising α-glucosidase and α-amylase inhibitors based on benzimidazole-oxadiazole hybrid analogues: Evidence-based in vitro and in silico studies. Results in Chemistry, 11, 101832.

Aleid, G., Ahmad Abbasi, S., Ullah, H., Niaz, Z., Taha, M. (2024). Design, synthesis, biological evaluation and molecular docking study of thiadiazole-isatin hybrid analogues as potential anti-diabetic and anti-bacterial agents. Results in Chemistry, 11, 101805.

Amjid, Z., Khan, S., Iqbal, T., Ullah, R., Ali, E.A. (2024). Synthesis, confirmations, and biological evaluation of acid-substituted Schiff base derivatives: Unraveling insight through SAR, DFT, ADMET, and molecular docking. Results in Chemistry, 11, 101744.

Aleid, G., Imran, M., Ullah, H., Iqbal, R., Abdel-Hameed, R. (2024). Design, synthesis, in vitro bio-evaluation and in silico molecular docking study of benzohydrazide-based thiourea analogues. Results in Chemistry, 11, 101756.

Naz, H., Othman, M.S., Rahim, F., Khan, Y., Shah, S.A.A. (2024). Investigation of novel benzimidazole-based indole/thiazole hybrids derivatives as effective anti-diabetics and anti-Alzheimer’s agents: Structure-activity relationship insight, in vitro and in silico approaches. Journal of Molecular Structure, 1312, 138592.

Othman, M.S., Naz, H., Rahim, F., Iqbal, R., Adnan Ali Shah, S. (2024). New cholinesterase inhibitors based on 1,2,4-triazole bearing benzenesulfonohydrazide skeleton: Synthesis, in vitro and in silico studies. Results in Chemistry, 10, 101717.

Continue reading “Hayat Ullah | Pharmacology | Best Researcher Award “ →

Paweł Rajewski | Cardiovascular risk | Best Research Article Award | Best Research Article Award

Published on 11/11/202411/11/2024 by Cardiology and Cardiovascular Medicine

Prof Dr. Paweł Rajewski | Cardiovascular risk | Best Research Article Award

Prof Dr. Paweł Rajewski, WSOZ, Poland

🌟Bioinformatics:

Prof. Dr. Paweł Rajewski is a leading expert in internal medicine, infectious diseases, hepatology, and clinical transplantation. Serving as the Rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz, Poland, he is also the Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship. In addition, he heads both the Department of Internal Medicine and Infectious Diseases at Tadeusz Browicz Provincial Infectious Disease Hospital and the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Dr. Rajewski is a certified lipidologist and obesitologist, with over 200 published articles focusing on metabolic disorders, liver diseases, and cardiovascular health. He is also the founder of the Dr. Rajewski Foundation, which supports research and education in health sciences.

Profile:

Orcid Profile

🏥Current Position and Roles:

Dr. Paweł Rajewski is a distinguished medical doctor, professor, and the rector of the Faculty of Health Sciences at the University of Health Sciences in Bydgoszcz. He holds the vital role of Provincial Consultant in Infectious Diseases for the Kuyavian-Pomeranian Voivodeship, providing oversight and strategic insights on infectious disease management in the region. Dr. Rajewski serves as the Head of the Department of Internal Medicine and Infectious Diseases at the Tadeusz Browicz Provincial Infectious Disease Hospital in Bydgoszcz, as well as the Head of the Liver, Internal, Infectious, and Metabolic Disorders Clinic at CM Gizińscy in Bydgoszcz. Previously, he served as the Medical Director and Head of the Department of Internal Medicine and Hepatology at the Emil Warmiński Multispecialist City Hospital. Through these roles, he contributes to the health of countless patients while also shaping medical policy and practice.

🎓Academic Background:

Dr. Rajewski’s academic journey has been marked by an enduring commitment to medicine, specializing in areas such as internal medicine, infectious diseases, hepatology, and clinical transplantation. His qualifications in these areas form the bedrock of his clinical and academic expertise, enabling him to deliver high-impact research and patient care in fields that are central to public health. Dr. Rajewski’s education includes specialty certifications as a lipidologist, accredited by the Polish Lipid Association, and an obesitologist with certifications from the Polish Association for the Study of Obesity and the Polish Society for Obesity Treatment.

📚Research Interests and Publication Achievements:

Dr. Rajewski has contributed over 200 articles, primarily focused on metabolic disorders, obesity, liver diseases, and cardiovascular risk factors. His work, published in reputed medical journals, has been instrumental in advancing knowledge on these critical health issues. His research sheds light on complex metabolic processes, influencing both preventive and therapeutic approaches to conditions like non-alcoholic fatty liver disease and atherosclerosis. His publications are widely recognized for their scientific rigor and relevance, contributing to his esteemed reputation in the medical research community.

🔬Ongoing Research Projects:

Dr. Rajewski is currently engaged in various research projects that address emerging concerns in metabolic health and infectious diseases. His work on liver disease mechanisms and cardiovascular risk factors associated with obesity and metabolic syndrome aims to uncover better diagnostic markers and treatment pathways. A recent focus involves studying COVID-19’s impact on liver function and the interplay between viral infections and metabolic health, topics highly relevant in today’s healthcare landscape.

👥Professional Associations and Certifications:

Dr. Rajewski’s memberships in prestigious medical associations, including the Polish Lipid Association and the Polish Association for the Study of Obesity, underscore his dedication to staying at the forefront of medical science. His certified expertise as a lipidologist and obesitologist enables him to approach health issues with a comprehensive understanding of lipid and metabolic disorders, enhancing the efficacy of treatments and preventive measures.

🏆Scholarships and Awards:

Dr. Rajewski’s contributions to medicine have earned him numerous accolades, recognizing his achievements in research and clinical practice. These awards celebrate his innovation in metabolic research and his pivotal role in infectious disease management. His scholarship funding reflects a legacy of excellence and a commitment to advancing medical science.

📖Training & Workshops Attended:

In his pursuit of continual growth, Dr. Rajewski has attended a series of specialized workshops on bioinformatics, advanced diagnostics, and clinical applications in infectious disease management. These workshops equip him with cutting-edge skills that he applies to his daily work, benefiting patients and enhancing the training of his medical students.

💻Contributions to Bioinformatics and Clinical Research:

A proficient bioinformatician, Dr. Rajewski integrates data science and computational tools in his research on metabolic diseases and infectious pathogens. By utilizing bioinformatics, he has been able to analyze complex datasets, leading to insights into genetic predispositions and disease progression. His ability to harness bioinformatics tools strengthens his work in both metabolic and infectious disease studies, positioning him at the cutting edge of medical research.

🎤Oral Presentations and Conferences:

As a frequent presenter at national and international conferences, Dr. Rajewski shares his research findings with the medical community. His presentations cover topics like liver disease pathogenesis, metabolic syndrome treatments, and emerging infectious diseases. He contributes actively to knowledge exchange, with his lectures serving as valuable learning resources for both peers and students.

📊Key Tasks and Responsibilities as a Researcher:

In his research role, Dr. Rajewski coordinates multi-disciplinary teams, designing studies, and conducting extensive data analyses. His responsibilities include overseeing clinical trials and ensuring the ethical integrity of research protocols. His dedication to stringent research standards has led to significant findings that improve patient care protocols and inform public health strategies.

🌠Success Factors:

Dr. Rajewski attributes his success to his commitment to continuous learning, innovation, and collaboration. His ability to bridge theoretical research with practical applications in healthcare makes his contributions exceptionally valuable. Additionally, his leadership in the clinical setting exemplifies his holistic approach to healthcare, balancing research with direct patient care.

🔍Publications & Laboratory Experience:

Dr. Rajewski’s extensive laboratory experience includes advanced diagnostics in liver diseases, where he employs innovative techniques to diagnose and manage conditions like hepatitis and liver fibrosis. His publications detail his findings on the effectiveness of new biomarkers, offering insights that enhance both diagnostics and treatment options for liver and metabolic disorders.

🌐Conclusion:

Dr. Paweł Rajewski’s career exemplifies a dedication to excellence in medicine, research, and public health. His multifaceted expertise in internal medicine, infectious diseases, and metabolic health has propelled him to the forefront of healthcare in Poland. Dr. Rajewski’s contributions are invaluable to the fields of hepatology and infectious disease, positively impacting patient care and advancing medical knowledge. Through his foundation, research, and clinical roles, he continues to shape the future of health sciences, creating a lasting legacy of compassion, knowledge, and innovation.

Top Notable Publications:

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults